MSD Cytokine Profiling & Multiplex Immunoassay Services

Analytical Requirements for Cytokine Multiplexing

Cytokines span an extraordinary concentration range — from sub-pg/mL (IL-4, IL-5) to ng/mL (acute-phase cytokines) — and exhibit complex cross-reactivity patterns due to shared receptor subunits and structural homology within cytokine families (IL-1 family, IL-6 family, chemokine CC/CXC subfamilies). Fluorescent bead-based platforms address the multiplex need but introduce spectral overlap at moderate-to-high plex densities, requiring compensation algorithms that propagate uncertainty into low-abundance cytokine measurements — precisely where precision matters most.

ECL Advantages for Cytokine Multiplexing

• Spatial spot separation — each capture antibody occupies a discrete electrode within the well, electrically addressed in sequence; no fluorescent emission spectra to deconvolve, no compensation gating, no signal bleed-through between structurally related cytokines
• SULFO-TAG ECL labels — non-enzymatic, chemically stable detection; light emitted only upon electrical stimulation at the electrode surface means zero autofluorescence background from serum, plasma, or tissue culture supernatant matrices
• 4–5 log dynamic range per analyte — measure IL-6 at ng/mL and IL-4 at sub-pg/mL in the same well under identical conditions, without dilution adjustments or sensitivity compromises
• Carbon electrode surface — approximately 10× higher binding capacity than polystyrene ELISA plates, extending the lower limit of detection for low-abundance targets
• Lot-to-lot consistency — V-PLEX panels include bridging data between reagent lots, supporting multi-year longitudinal studies and multi-site trials with documented analytical continuity

MSD Product Lines for Cytokine Research

• V-PLEX — Validated multiplex panels. Manufacturer-pre-validated with full analytical documentation (LOD, LLOQ, precision, linearity, spike recovery, cross-reactivity screening). Ready-to-use with lot-to-lot bridging data. The standard choice for regulated-quality cytokine data in preclinical and translational research.
• U-PLEX — Custom-configurable multiplex. Select any 2–10 analytes from the available cytokine and chemokine target catalog. Linker-coupled antibodies provide complete configuration flexibility without custom development timelines. Requires feasibility evaluation for novel target combinations to confirm assay compatibility.
• S-PLEX — Ultrasensitive single-analyte assays. fg/mL LOD via enhanced signal amplification. Designed for low-abundance cytokines where standard assay sensitivity is insufficient (e.g., IL-4, IL-5, IL-13 at baseline in plasma). Single-plex format optimized for maximum sensitivity.
• R-PLEX — Custom single-analyte development. For cytokine targets not covered by existing V-PLEX or S-PLEX assays. Requires antibody pairing and optimization — contact us for feasibility assessment and development timeline.

Plasma (EDTA)

Collect in EDTA tubes. Centrifuge within 30 min at 1,500×g for 10 min at 4°C. Transfer supernatant, aliquot into polypropylene cryovials, and freeze at −80°C. EDTA plasma is preferred for most cytokine panels — the clotting process in serum collection can introduce pre-analytical cytokine variability. Heparin and citrate also acceptable for most panels.

Serum

Collect in serum separator tubes (SST). Allow 30 min clotting at RT. Centrifuge at 1,500×g for 10 min at 4°C. Aliquot and freeze at −80°C. Consistent clotting time is critical — prolonged clotting releases platelet-derived cytokines (TGF-β1, PDGF-BB) that may bias measurements. Note matrix type in metadata; do not mix serum and plasma within a study.

CSF

Collect in polypropylene tubes. Centrifuge at 2,000×g for 10 min at 4°C. Aliquot immediately into polypropylene cryovials and store at −80°C. CSF is low-protein and low-volume — 25 µL per well is especially valuable given limited CSF availability. Supported by all MSD cytokine and chemokine panels with documented matrix performance data.

Cell Culture Supernatant

Centrifuge at 300×g for 5 min to remove cells, then at 2,000×g for 10 min to remove debris. Aliquot and freeze at −80°C. Note medium composition — serum-containing media introduces bovine cytokines that may cross-react with certain assays. Serum-free or low-serum conditions recommended where feasible. Include media-only controls for background subtraction.

Tissue Lysate & Homogenate

Flash-freeze tissue at collection. Homogenize in appropriate lysis buffer with protease inhibitors. Centrifuge at 14,000×g for 10 min at 4°C to clear debris. Aliquot supernatant and freeze at −80°C. Total protein normalization recommended — report cytokine concentrations per mg total protein. Lysis buffer compatibility verified during project consultation.

BAL Fluid & Other Matrices

Bronchoalveolar lavage (BAL), synovial fluid, urine, and other non-standard matrices are supported on consultation. Matrix-specific validation may be required — contact our scientific team to discuss feasibility for your specific matrix. Dilution linearity and spike recovery verification recommended for matrices not previously characterized with your panel of interest.

No Spectral Overlap — At Any Plex Level

Each analyte occupies a discrete electrode spot, electrically addressed in sequence. Fluorescent bead-based systems (Luminex) deconvolve overlapping emission spectra — a process that introduces compensation error and disproportionately affects low-abundance cytokines. MSD's spatial separation eliminates this problem entirely: 4-plex or 54-plex, every analyte gets an independent signal channel.

4–5 Log Dynamic Range per Analyte

Measure IL-6 at ng/mL and IL-4 at sub-pg/mL in the same well under identical conditions. Fluorescent bead platforms typically offer 2–3 logs — requiring dilution adjustments that introduce pre-analytical variability when high- and low-abundance cytokines are measured together.

Background-Free ECL Detection

SULFO-TAG labels emit light only upon electrical stimulation at the electrode surface — no excitation light source means zero autofluorescence from serum, plasma, or tissue culture media. This is critical for low-pg/mL cytokine quantification, where matrix autofluorescence in optical systems can exceed the analyte signal.

70-Second Plate Read — Not 45–60 Minutes

MSD's electrical readout acquires all 96 wells in ~70 seconds. Fluorescent bead systems require 45–60 minutes of sequential laser interrogation per plate — a throughput difference that matters when running large cohort studies or multiple panels per sample.

25 µL for Any Plex Level

A 54-plex consumes the same sample volume as a single ELISA well. Sample volume is independent of the number of analytes measured — preserving precious longitudinal aliquots, pediatric samples, and CSF for additional analyses.

One Platform, Discovery to Validation

The same ECL detection chemistry across V-PLEX, U-PLEX, and S-PLEX product lines means you can discover biomarkers with the 54-Plex, narrow to a focused U-PLEX panel, and validate with S-PLEX sensitivity — all on one instrument family, eliminating cross-platform variability.